290 related articles for article (PubMed ID: 25409232)
1. Berberine improves kidney function in diabetic mice via AMPK activation.
Zhao L; Sun LN; Nie HB; Wang XL; Guan GJ
PLoS One; 2014; 9(11):e113398. PubMed ID: 25409232
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol via activation of LKB1-AMPK signaling suppresses oxidative stress to prevent endothelial dysfunction in diabetic mice.
Hu M; Liu B
Clin Exp Hypertens; 2016; 38(4):381-7. PubMed ID: 27149559
[TBL] [Abstract][Full Text] [Related]
3. Berberine Pretreatment Confers Cardioprotection Against Ischemia-Reperfusion Injury in a Rat Model of Type 2 Diabetes.
Chang W; Li K; Guan F; Yao F; Yu Y; Zhang M; Hatch GM; Chen L
J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):486-94. PubMed ID: 26846272
[TBL] [Abstract][Full Text] [Related]
4. Protective Effects of Berberine on Renal Injury in Streptozotocin (STZ)-Induced Diabetic Mice.
Zhang X; He H; Liang D; Jiang Y; Liang W; Chi ZH; Ma J
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27529235
[TBL] [Abstract][Full Text] [Related]
5. Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice.
Yang G; Zhao Z; Zhang X; Wu A; Huang Y; Miao Y; Yang M
Drug Des Devel Ther; 2017; 11():1065-1079. PubMed ID: 28408805
[TBL] [Abstract][Full Text] [Related]
6. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling.
Xie X; Chang X; Chen L; Huang K; Huang J; Wang S; Shen X; Liu P; Huang H
Mol Cell Endocrinol; 2013 Dec; 381(1-2):56-65. PubMed ID: 23896433
[TBL] [Abstract][Full Text] [Related]
7. Renoprotective effects of berberine and its possible molecular mechanisms in combination of high-fat diet and low-dose streptozotocin-induced diabetic rats.
Wang FL; Tang LQ; Yang F; Zhu LN; Cai M; Wei W
Mol Biol Rep; 2013 Mar; 40(3):2405-18. PubMed ID: 23196710
[TBL] [Abstract][Full Text] [Related]
8. Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway.
Zhu L; Han J; Yuan R; Xue L; Pang W
Biol Res; 2018 Mar; 51(1):9. PubMed ID: 29604956
[TBL] [Abstract][Full Text] [Related]
9. Highly bioavailable berberine formulation ameliorates diabetic nephropathy through the inhibition of glomerular mesangial matrix expansion and the activation of autophagy.
Zhang M; Zhang Y; Xiao D; Zhang J; Wang X; Guan F; Zhang M; Chen L
Eur J Pharmacol; 2020 Apr; 873():172955. PubMed ID: 32001218
[TBL] [Abstract][Full Text] [Related]
10. AMP-activated protein kinase (AMPK) activation inhibits nuclear translocation of Smad4 in mesangial cells and diabetic kidneys.
Zhao J; Miyamoto S; You YH; Sharma K
Am J Physiol Renal Physiol; 2015 May; 308(10):F1167-77. PubMed ID: 25428125
[TBL] [Abstract][Full Text] [Related]
11. Berberine Protects Human Retinal Pigment Epithelial Cells from Hydrogen Peroxide-Induced Oxidative Damage through Activation of AMPK.
Li S; Gaur U; Chong CM; Lin S; Fang J; Zeng Z; Wang H; Zheng W
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895743
[TBL] [Abstract][Full Text] [Related]
12. Berberine reduces ischemia/reperfusion-induced myocardial apoptosis via activating AMPK and PI3K-Akt signaling in diabetic rats.
Chen K; Li G; Geng F; Zhang Z; Li J; Yang M; Dong L; Gao F
Apoptosis; 2014 Jun; 19(6):946-57. PubMed ID: 24664781
[TBL] [Abstract][Full Text] [Related]
13. Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose.
Liu W; Liu P; Tao S; Deng Y; Li X; Lan T; Zhang X; Guo F; Huang W; Chen F; Huang H; Zhou SF
Arch Biochem Biophys; 2008 Jul; 475(2):128-34. PubMed ID: 18471986
[TBL] [Abstract][Full Text] [Related]
14. Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action.
Turner N; Li JY; Gosby A; To SW; Cheng Z; Miyoshi H; Taketo MM; Cooney GJ; Kraegen EW; James DE; Hu LH; Li J; Ye JM
Diabetes; 2008 May; 57(5):1414-8. PubMed ID: 18285556
[TBL] [Abstract][Full Text] [Related]
15. The renoprotective effects of berberine via the EP4-Gαs-cAMP signaling pathway in different stages of diabetes in rats.
Yang Y; Ni W; Cai M; Tang L; Wei W
J Recept Signal Transduct Res; 2014 Dec; 34(6):445-55. PubMed ID: 24849498
[TBL] [Abstract][Full Text] [Related]
16. Cyclocarya paliurus triterpenic acids fraction attenuates kidney injury via AMPK-mTOR-regulated autophagy pathway in diabetic rats.
Zhang XX; Jiang CH; Liu Y; Lou DX; Huang YP; Gao M; Zhang J; Yin ZQ; Pan K
Phytomedicine; 2019 Nov; 64():153060. PubMed ID: 31401495
[TBL] [Abstract][Full Text] [Related]
17. Hepatoprotective effects of berberine on liver fibrosis via activation of AMP-activated protein kinase.
Li J; Pan Y; Kan M; Xiao X; Wang Y; Guan F; Zhang X; Chen L
Life Sci; 2014 Mar; 98(1):24-30. PubMed ID: 24412384
[TBL] [Abstract][Full Text] [Related]
18. Berberine improves insulin resistance in cardiomyocytes via activation of 5'-adenosine monophosphate-activated protein kinase.
Chang W; Zhang M; Li J; Meng Z; Wei S; Du H; Chen L; Hatch GM
Metabolism; 2013 Aug; 62(8):1159-67. PubMed ID: 23537779
[TBL] [Abstract][Full Text] [Related]
19. Berberine regulates the expression of E-prostanoid receptors in diabetic rats with nephropathy.
Tang LQ; Liu S; Zhang ST; Zhu LN; Wang FL
Mol Biol Rep; 2014 May; 41(5):3339-47. PubMed ID: 24488262
[TBL] [Abstract][Full Text] [Related]
20. Extracellular Superoxide Dismutase Attenuates Renal Oxidative Stress Through the Activation of Adenosine Monophosphate-Activated Protein Kinase in Diabetic Nephropathy.
Hong YA; Lim JH; Kim MY; Kim Y; Park HS; Kim HW; Choi BS; Chang YS; Kim HW; Kim TY; Park CW
Antioxid Redox Signal; 2018 Jun; 28(17):1543-1561. PubMed ID: 29020797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
